The cheapest place to order Mounjaro — what UK pricing actually means

What Eli Lilly's pricing change tells us about UK Mounjaro costs

In August 2025 Eli Lilly announced a significant list-price increase for Mounjaro in the UK, taking effect from 1 September 2025. The highest-dose pen's list price moved from around £122 to around £330 for a four-week supply. That single change shifted the entire private market upward almost overnight. Providers who were competing heavily on price found their margins compressed, and some adjusted their structures accordingly. Mounjaro market prices now sit in a meaningfully higher band than they did in 2024, and any price you see quoted before that date is out of date.

NICE's appraisal of tirzepatide, published as TA1026 in December 2024, confirmed the medicine's clinical value for weight management in eligible adults, but NHS access remains strictly phased and rationed by comorbidity criteria. For the majority of people seeking treatment privately, the private market is the realistic route, and the going rate reflects that demand. The full Mounjaro overview sets out the clinical picture behind those numbers.

What headline prices typically leave out

A quoted monthly figure for Mounjaro can mean different things at different providers. Some include a consultation fee paid separately at sign-up. Others charge for the prescription itself or for dose-review appointments when you want to move up to the next strength. Delivery charges (sometimes £5, sometimes more) get added at checkout. Aftercare, when it's offered at all, can sit behind a separate monthly membership.

None of that is necessarily dishonest, but it does make direct price comparisons unreliable. A £149 headline that arrives with a £25 consultation fee, a £10 prescription charge and a £6 delivery cost has already closed most of the gap on a higher but fully inclusive price. The cheapest place to buy Mounjaro comparison is worth reading if you're working through provider claims carefully.

Our prescribers also deal regularly with patients who've transferred from providers where dose increases required new consultations billed separately, sometimes at a cost that hadn't been mentioned upfront. Worth checking the small print before assuming the lowest starting price stays low.

Where nume sits in the market, and why that's deliberate

We're not going to claim the lowest price. We chose not to compete on that basis, and it's a decision we stand behind. One transparent price at nume covers the consultation, the prescription, the medicine, next-working-day DPD delivery, and seven-day aftercare, nothing held back for an upsell, no subscription you have to remember to cancel. Current treatment pricing is on the weight-loss treatments page.

Every repeat order goes through clinical re-review before dispatch. A real prescriber reads your consultation (not an automated decision engine) the same day you submit it. Dose increases require evidence. That structure costs something to run, and it's reflected in the price. If you're moving up to the 7.5 mg strength and want to know where to find the best value on 7.5 mg Mounjaro through a legitimate provider, our prescribers can walk you through the options. If you order before noon on a working day and your prescriber approves treatment, your pen leaves our GPhC-registered pharmacy the same day (GPhC premises registration: 9012878).

Payday orders, Monday morning rushes, holiday-week submissions, whatever the timing, the clinical review process doesn't change. The 12pm dispatch cut-off is consistent, and DPD tracking arrives on your phone once the order ships.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has warned publicly about counterfeit Mounjaro pens circulating through social media and unverified online sellers. In October 2025, enforcement teams raided the first illicit UK site manufacturing fake tirzepatide pens, and prior to that approximately 20 million doses of illegally traded weight-loss medicines (around £45 million in estimated street value) had been seized. Fake pens have been found to contain insulin in some cases, a potentially life-threatening substitution.

The common thread in counterfeit cases is price. Pens sold far below market rates, without a full clinical assessment, through channels you can't verify on the GPhC pharmacy register, are the ones most likely to be unsafe or counterfeit. The MHRA's guidance (summarised on GOV.UK under GLP-1 medicines for weight loss and diabetes: what you need to know) is direct: only obtain these medicines through a registered pharmacy following a legitimate prescription. You can report suspect sellers at yellowcard.mhra.gov.uk.

For a prescription-only medicine, cheapest is not the metric that protects you. Clinical oversight, a verifiable supply chain, and a prescriber who knows your medical history are. Those things have a cost, and it's a cost that's worth paying. If you'd like to understand the options available through legitimate UK routes, our prescribers can help you work out what's clinically right for you.